Huguette Schultz

576 total citations
11 papers, 440 citations indexed

About

Huguette Schultz is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Huguette Schultz has authored 11 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Huguette Schultz's work include Virus-based gene therapy research (5 papers), Cystic Fibrosis Research Advances (3 papers) and CAR-T cell therapy research (2 papers). Huguette Schultz is often cited by papers focused on Virus-based gene therapy research (5 papers), Cystic Fibrosis Research Advances (3 papers) and CAR-T cell therapy research (2 papers). Huguette Schultz collaborates with scholars based in France, Spain and United States. Huguette Schultz's co-authors include Andréa Pavirani, Majid Mehtali, A Dieterlé, Karola Rittner, Dominique Dreyer, Brigitte Mourot, Marielle Christ, Fabienne Stoeckel, Monika Lusky and A. Bout and has published in prestigious journals such as PLoS ONE, Journal of Virology and Human Gene Therapy.

In The Last Decade

Huguette Schultz

11 papers receiving 428 citations

Peers

Huguette Schultz

GENET

ONCOL

EPIDE

Hoyin Mok United States

Raúl Alba United Kingdom

Fabienne Stoeckel France

Lisa Cardoza United States

Hoorig Nassanian United States

Roswitha Gerhards Germany

FL Graham Canada

Marianne G. Rots Netherlands

Roland H. Stauber Germany

Dana Haddad United States

Hoyin Mok United States

Huguette Schultz

336 ×1.1

318 ×1.0

GENET

122 ×1.2

ONCOL

74 ×0.8

25 ×0.6

EPIDE

Citations per year, relative to Huguette Schultz Huguette Schultz (= 1×) peers Hoyin Mok

Countries citing papers authored by Huguette Schultz

Since Specialization

Citations

This map shows the geographic impact of Huguette Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huguette Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huguette Schultz more than expected).

Fields of papers citing papers by Huguette Schultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huguette Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huguette Schultz. The network helps show where Huguette Schultz may publish in the future.

Co-authorship network of co-authors of Huguette Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Huguette Schultz. A scholar is included among the top collaborators of Huguette Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huguette Schultz. Huguette Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Schmitt, D, Aurélie Ray, Chantal Hoffmann, et al.. (2018). A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis. PLoS ONE. 13(5). e0196815–e0196815. 14 indexed citations

Rasmussen, Ulla, et al.. (2002). Tumor cell-targeting by phage-displayed peptides. Cancer Gene Therapy. 9(7). 606–612. 53 indexed citations

Lusky, Monika, Marielle Christ, Karola Rittner, et al.. (1998). In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted. Journal of Virology. 72(3). 2022–2032. 209 indexed citations

Christ, Marielle, Fabienne Stoeckel, Monika Lusky, et al.. (1997). Gene therapy with recombinant adenoviral vectors: in vivo immune evaluation. Immunology Letters. 56. 38–38. 1 indexed citations

Rittner, Karola, Huguette Schultz, Andréa Pavirani, & Majid Mehtali. (1997). Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro. Journal of Virology. 71(4). 3307–3311. 22 indexed citations

Dupuit, Florence, Cécile Chartier, Nathalie Accart, et al.. (1996). Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter.. PubMed. 3(1). 49–58. 32 indexed citations

Imler, Jean‐Luc, A. Bout, Dominique Dreyer, et al.. (1995). Trans -Complementation of E1-Deleted Adenovirus: A New Vector to Reduce the Possibility of Codissemination of Wild-Type and Recombinant Adenoviruses. Human Gene Therapy. 6(6). 711–721. 30 indexed citations

Sené, Claude, A. Bout, Jean‐Luc Imler, et al.. (1995). Aerosol-Mediated Delivery of Recombinant Adenovirus to the Airways of Nonhuman Primates. Human Gene Therapy. 6(12). 1587–1593. 29 indexed citations

Bout, A., Huguette Schultz, Michel Perricaudet, et al.. (1994). In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.. PubMed. 1(6). 385–94. 37 indexed citations

10.

Perraud, F., Kazuya Yoshimura, B. Gregory Louis, et al.. (1992). The promoter of the human cystic fibrosis transmembrane conductance regulator gene directing SV40 T antigen expression induces malignant proliferation of ependymal cells in transgenic mice.. PubMed. 7(5). 993–7. 10 indexed citations

11.

Bischoff, Rainer, Wilfried Dalemans, Hervé Pointu, et al.. (1990). [Production of human proteins in the blood of transgenic animals].. PubMed. 311(8). 275–80. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact